Sign in to continue:

Saturday, April 11th, 2026

BiomX Acquires Zorronet to Expand AI Command-and-Control Capabilities in $81B Defense and Security Market by 2030 1




BiomX Acquires Zorronet: Strategic Expansion into Defense and Security

BiomX Inc. Completes Acquisition of Zorronet, Marking Major Entry into Defense, Security, and Rescue Markets

Key Highlights of the Acquisition

  • Acquisition of 100% of Zorronet: BiomX Inc. (NYSE American: PHGE) has completed the acquisition of Zorronet, a leading developer of autonomous, AI-powered command-and-control platforms, from Water.io (TASE: WATR).
  • Strategic Market Entry: This move marks BiomX’s formal entry into the rapidly growing defense, security, and rescue sectors, and lays a foundation for a diversified portfolio in these areas.
  • Addressing \$81 Billion Market Opportunity by 2030: The combined global command-and-control and video analytics markets are projected to reach \$81 billion by 2030, driven by the need for real-time situational awareness in defense and security environments.

About Zorronet’s Technology and Market Presence

  • AI-Powered Command-and-Control Platform: Zorronet’s software integrates AI and machine learning to unify video analytics, drones, sensors, and IoT devices. It analyzes multiple data streams simultaneously, detecting and classifying threats in near real time. This unification enables more efficient, actionable decision-making in complex environments.
  • Operational Deployments & Contracts: Zorronet’s technology is currently deployed with the Israel Defense Forces and critical infrastructure operators, including Israel Railways. The company also serves major government clients, Tier-1 OEMs such as Elbit Systems, and international customers, underscoring its credibility and operational track record.
  • Mission-Critical Applications: The platform is used in high-stakes defense and security environments, where real-time situational awareness and rapid response are essential.

Strategic Synergy and Future Growth Potential

  • Complementary Acquisition Option: BiomX previously announced an option to acquire control of DFSL, an Israeli LADAR (Laser Detection and Ranging) solutions company. DFSL specializes in counter-unmanned aerial systems (C-UAS), perimeter and border security, and advanced detection technologies. Both Zorronet and DFSL have demonstrated their technologies in real-world defense and critical infrastructure settings, strengthening BiomX’s future portfolio.
  • Unified Operational Intelligence: The integration of Zorronet’s platform addresses a significant industry challenge: operators often rely on multiple disconnected systems, which increases response times and the risk of missed threats. Zorronet enables unified data analysis from cameras, drones, sensors, and IoT devices, turning passive monitoring into active threat management.
  • Market Growth Trends: Industry forecasts predict the global command and control systems market will reach approximately \$44 billion by 2030, with the global video analytics market exceeding \$37 billion. These trends are driven by growing demand for integrated situational awareness and AI-enabled decision-support platforms.

Management Commentary

“The acquisition of Zorronet strengthens our ability to support real-time decision-making across complex security environments. As the volume of data generated by sensors, drones, and connected systems continues to grow, the ability to interpret that data efficiently and respond in a timely manner becomes increasingly important. This acquisition marks an important step in our entry into the defense sector and our focus on acquiring and building a diversified portfolio across defense, rescue, and security sectors.”

— Michael Oster, Chief Executive Officer of BiomX

Investor Takeaways & Price-Sensitive Information

  • Transformation of Business Model: BiomX’s acquisition of Zorronet signals a significant strategic shift from its historical focus and positions the company as a new entrant in large, fast-growing defense and security markets. This could drive a re-rating of the company’s shares as it diversifies revenue streams and aligns with global defense spending trends.
  • Exposure to Mission-Critical and Government Contracts: Zorronet’s existing contracts with the Israel Defense Forces, critical infrastructure clients, and Tier-1 OEMs offer immediate credibility and future growth potential, which may impact BiomX’s financial performance and valuation.
  • Potential for Additional Strategic Acquisitions: With the option to acquire DFSL and a stated focus on building a diversified defense/security portfolio, BiomX may continue to pursue further expansion, which could be materially significant for investors.
  • Market Opportunity: With the addressable market for command-and-control and video analytics solutions approaching \$81 billion by 2030, BiomX’s expanded offerings place it in a strong position to capitalize on these trends.
  • Synergies and Integration: The integration of Zorronet’s platform is expected to improve operational efficiency and enhance product offerings, potentially leading to increased market share and profitability.

Further Information

Investors are encouraged to review BiomX’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission for additional details regarding the transaction and its strategic implications.

Contact

Michael Oster
[email protected]

Disclaimer

Disclaimer: This article contains forward-looking statements, including those regarding the expected benefits of the acquisition, BiomX’s business strategy, and market opportunities. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Investors should refer to BiomX’s filings with the SEC for a full discussion of risks and are reminded that past performance is not indicative of future results. This article is for informational purposes only and does not constitute investment advice.




View BiomX Inc. Historical chart here



Netskope One Platform: Redefining Security and Networking for the Cloud and AI Era

Netskope 2026 Annual Report: Key Investor Insights Net...

Crinetics Pharmaceuticals, Inc. Files Form 8-K with SEC: Company Details, Stock Info, and Compliance Data (March 2026)

Crinetics Pharmaceuticals Announces Resignation of Chief Dev...

   Ad